Literature DB >> 30811709

Moderators and predictors of outcome in metacognitive and cognitive behavioural therapy for co-morbid anxiety disorders.

Sverre Urnes Johnson1, Asle Hoffart1,2.   

Abstract

This study aimed to investigate whether two theoretically derived moderators of treatment, degree of worry and avoidance at pretreatment, moderated anxiety from pretreatment to post-treatment in a randomized controlled trial comparing metacognitive therapy and cognitive behavioural therapy. Personality problems, degree of co-morbidity, and demographic characteristics (work status and education) were also investigated. Seventy-four patients with a primary diagnosis of post-traumatic stress disorder, social phobia, or panic disorder with and without agoraphobia were analysed using multilevel modelling. There were no significant predictors of treatment outcome, indicating that the slope was not dependent on worry, avoidance, personality problems, degree of co-morbidity, and demographic characteristics. Furthermore, no interaction with treatment condition was found. Due to the sample size, the results of the moderator analysis should be interpreted with caution and replicated. Worry, avoidance, personality problems, degree of co-morbidity, and demographic variables did not moderate the effect of metacognitive therapy and cognitive behavioural therapy or predict treatment outcome for co-morbid anxiety disorders. Clinical implications are discussed.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CBT; anxiety; co-morbidity; metacognitive therapy; moderator; predictor

Year:  2019        PMID: 30811709     DOI: 10.1002/cpp.2361

Source DB:  PubMed          Journal:  Clin Psychol Psychother        ISSN: 1063-3995


  1 in total

Review 1.  The Scope of Metacognitive Therapy in the Treatment of Psychiatric Disorders.

Authors:  Vandita Sharma; Rajesh Sagar; Gaurishanker Kaloiya; Manju Mehta
Journal:  Cureus       Date:  2022-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.